PRAF

Welcome to the Brand page for “PRAF”, which is offered here for In the statement, column 1, line 13, facial should be deleted, and, fascial should be inserted.;medicated transdermal patches, plasters, pads, and cataplasms for the temporary relief of aches of rheumatoid arthritis, and the aches and pains of muscles, joints and tendons; anti-inflammatory and analgesic agents; other pharmaceuticals for use in the treatment of lumbago, muscular and [facial] * fascial * lumbago, spondylosis deformans discopathy, and sprain of lumber spine, osteoarthritis, humeroscapular periarthritis, tendinitis, tendo-vaginitis, peritendinitis, humeral epicondylitis, tennis elbow, myalgia and post-traumatic swelling and pain;.

Its status is currently believed to be active. Its class is unavailable. “PRAF” is believed to be currently owned by “HISAMITSU PHARMACEUTICAL CO., INC.”


Owner:
HISAMITSU PHARMACEUTICAL CO., INC.
Owner Details
Description:
In the statement, column 1, line 13, facial should be deleted, and, fascial should be inserted.;Medicated transdermal patches, plasters, pads, and cataplasms for the temporary relief of aches of rheumatoid arthritis, and the aches and pains of muscles, joints and tendons; anti-inflammatory and analgesic agents; other pharmaceuticals for use in the treatment of lumbago, muscular and [facial] * fascial * lumbago, spondylosis deformans discopathy, and sprain of lumber spine, osteoarthritis, humeroscapular periarthritis, tendinitis, tendo-vaginitis, peritendinitis, humeral epicondylitis, tennis elbow, myalgia and post-traumatic swelling and pain;
Categories: STATEMENT